These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1448658

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
    Maeda T, Hoshino T.
    No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
    [Abstract] [Full Text] [Related]

  • 3. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
    Nagashima T, Hoshino T.
    No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
    [Abstract] [Full Text] [Related]

  • 4. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine.
    Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson BA, Davis RL, Wilson CB.
    Int J Cancer; 1992 Jan 02; 50(1):1-5. PubMed ID: 1728598
    [Abstract] [Full Text] [Related]

  • 5. Cell kinetics of rat 9L brain tumors determined by double labeling with iodo- and bromodeoxyuridine.
    Asai A, Shibui S, Barker M, Vanderlaan M, Gray JW, Hoshino T.
    J Neurosurg; 1990 Aug 02; 73(2):254-8. PubMed ID: 2366082
    [Abstract] [Full Text] [Related]

  • 6. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
    Giordano M, Riccardi A, Danova M, Brugnatelli S, Mazzini G.
    Cancer Detect Prev; 1991 Aug 02; 15(5):391-6. PubMed ID: 1751950
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cell kinetics of head and neck cancers.
    Kotelnikov VM, Coon JS IV, Haleem A, Taylor S IV, Hutchinson J, Panje W, Caldarelli DD, Griem K, Preisler HD.
    Clin Cancer Res; 1995 May 02; 1(5):527-37. PubMed ID: 9816012
    [Abstract] [Full Text] [Related]

  • 9. Final report on the University of California-San Francisco experience with bromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients.
    Lamborn KR, Prados MD, Kaplan SB, Davis RL.
    Cancer; 1999 Feb 15; 85(4):925-35. PubMed ID: 10091772
    [Abstract] [Full Text] [Related]

  • 10. [A cell kinetic study of human central nervous system tumors with 5-bromodeoxyuridine (BrdU)].
    Nagashima T, Hoshino T.
    No To Shinkei; 1985 Dec 15; 37(12):1195-201. PubMed ID: 3912000
    [Abstract] [Full Text] [Related]

  • 11. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y, Taomoto K, Saya H, Ijichi A, Kudo H, Kokunai T, Tamaki N, Matsumoto S.
    No To Shinkei; 1989 Apr 15; 41(4):383-90. PubMed ID: 2765301
    [Abstract] [Full Text] [Related]

  • 12. Variability in the proliferative potential of human gliomas.
    Hoshino T, Nagashima T, Cho KG, Davis RL, Donegan J, Slusarz M, Wilson CB.
    J Neurooncol; 1989 Jul 15; 7(2):137-43. PubMed ID: 2550593
    [Abstract] [Full Text] [Related]

  • 13. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MS, Gutin PH, Davis RL, DeArmond SJ.
    J Neurosurg; 1986 Mar 15; 64(3):453-9. PubMed ID: 3950723
    [Abstract] [Full Text] [Related]

  • 14. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
    Corvò R, Giaretti W, Margarino G, Danova M, Vitale V.
    Radiol Med; 1991 Mar 15; 82(1-2):147-52. PubMed ID: 1896568
    [Abstract] [Full Text] [Related]

  • 15. A new method for analyzing the cell kinetics of human brain tumors by double labeling with bromodeoxyuridine in situ and with iododeoxyuridine in vitro.
    Shibuya M, Ito S, Davis RL, Wilson CB, Hoshino T.
    Cancer; 1993 May 15; 71(10):3109-13. PubMed ID: 8490840
    [Abstract] [Full Text] [Related]

  • 16. Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling.
    Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, Wilson CB.
    Neurosurgery; 1992 Apr 15; 30(4):494-7; discussion 497-8. PubMed ID: 1584346
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Cellular kinetics of cerebral glioma: study of the proliferative activity using monoclonal antibody Ki 67. Apropos of 60 cases].
    Parent M, Blond S, Gosset P, Lejeune JP, Lesoin F, Dhellemmes P, Jomin M, Christiaens JL, Dupont A.
    Arch Anat Cytol Pathol; 1990 Apr 15; 38(3):81-5. PubMed ID: 2363592
    [Abstract] [Full Text] [Related]

  • 19. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A, Danova M, Wilson G, Ucci G, Dörmer P, Mazzini G, Brugnatelli S, Girino M, McNally NJ, Ascari E.
    Cancer Res; 1988 Nov 01; 48(21):6238-45. PubMed ID: 3167869
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.